BacLite Rapid MRSA Clinical Performance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00541632
Recruitment Status : Terminated (performance variability)
First Posted : October 10, 2007
Last Update Posted : May 15, 2008
Information provided by:

Brief Summary:
The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.

Condition or disease
Methicillin Resistance

Study Type : Observational
Time Perspective: Prospective
Official Title: BacLite Rapid MRSA Clinical Performance
Study Start Date : October 2007
Actual Study Completion Date : March 2008

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Subjects 18 years or older
  • Subjects willing to document demographic characteristics
  • Subjects willing to have their nose swabbed
  • Subjects (or legal representative) willing to sign consent and authorization forms

Exclusion Criteria:

  • Subjects who use Vicks Sinex Nasal spray or other nasal sprays
  • Subjects with prescribed nasal medical devices where collecting samples may resent more than minimal risk to subjects
  • Subjects having nasal prosthetics, jewelry or trauma to the nose or anything that may prevents sampling the anterior nares
  • Investigator believes that subject is unsuitable for inclusion.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00541632

United States, Colorado
Denver Health Medical Center
Denver, Colorado, United States, 80204
United States, Georgia
Atlanta Institute for Medical Research, Inc.
Atlanta, Georgia, United States, 30030
United States, Illinois
Evanston Northwestern Healthcare
Evanston, Illinois, United States, 60201
United States, Iowa
University of Iowa
Iowa City, Iowa, United States, 52242
United States, Maryland
University of Maryland
Baltimore, Maryland, United States, 21201-1595
United States, Michigan
Wayne State University
Detroit, Michigan, United States, 48201
United States, Missouri
Washington University
St. Louis, Missouri, United States, 63110
United States, North Carolina
Wake Forest University
Winston-Salem, North Carolina, United States, 27157-1042
United States, Ohio
Cleveland Clinic
Cleveland, Ohio, United States, 44195
Sponsors and Collaborators
Principal Investigator: Werner E Bischoff Wake Forest University Identifier: NCT00541632     History of Changes
Other Study ID Numbers: 010737
First Posted: October 10, 2007    Key Record Dates
Last Update Posted: May 15, 2008
Last Verified: May 2008